PT1454137E - Utilização de um ligando marcado com especificidade para a molécula cd4 humana - Google Patents

Utilização de um ligando marcado com especificidade para a molécula cd4 humana Download PDF

Info

Publication number
PT1454137E
PT1454137E PT02804582T PT02804582T PT1454137E PT 1454137 E PT1454137 E PT 1454137E PT 02804582 T PT02804582 T PT 02804582T PT 02804582 T PT02804582 T PT 02804582T PT 1454137 E PT1454137 E PT 1454137E
Authority
PT
Portugal
Prior art keywords
migration
specificity
human
analysis
producing
Prior art date
Application number
PT02804582T
Other languages
English (en)
Inventor
Frank Emmrich
Raimund W Kinne
Ruediger Laub
Ullrich Pigla
Original Assignee
Biotectid Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotectid Gmbh filed Critical Biotectid Gmbh
Publication of PT1454137E publication Critical patent/PT1454137E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/13—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultrasonic waves
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT02804582T 2001-12-11 2002-12-09 Utilização de um ligando marcado com especificidade para a molécula cd4 humana PT1454137E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10160653 2001-12-11
DE10232189A DE10232189A1 (de) 2001-12-11 2002-07-16 Verwendung eines markierten Liganden mit Spezifität für das humane CD4-Molekül zur Herstellung eines Diagnostikums zur Analyse von Wanderungs- und/oder Verteilungsmustern von Zellpopulationen

Publications (1)

Publication Number Publication Date
PT1454137E true PT1454137E (pt) 2008-05-05

Family

ID=7708699

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02804582T PT1454137E (pt) 2001-12-11 2002-12-09 Utilização de um ligando marcado com especificidade para a molécula cd4 humana

Country Status (3)

Country Link
CY (1) CY1107410T1 (pt)
DE (1) DE10232189A1 (pt)
PT (1) PT1454137E (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4112640A1 (en) * 2021-06-29 2023-01-04 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Novel single domain antigen binding molecules and their uses

Also Published As

Publication number Publication date
DE10232189A1 (de) 2003-06-18
CY1107410T1 (el) 2012-12-19

Similar Documents

Publication Publication Date Title
HK1041950A1 (zh) 臨床及診斷資料庫
AU2002211503A1 (en) Computerized interface for constructing and executing computerized transaction processes and programs
CA96302S (en) Blood glucose monitoring device
EP1187844A4 (en) POLYMORPHISM OF HUMAN CARBAMYLPHOSPHATE SYNTHETASE I AND RELATED DIAGNOSTIC AND THERAPEUTIC METHODS
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
EP1319178A4 (en) METHOD FOR IDENTIFYING CANCER MARKERS AND USES THEREOF FOR DIAGNOSING CANCER
EP1421905A4 (en) TISSUE IDENTIFICATION METHOD IN ULTRASONOGRAPHY AND ULTRASONIC UNIT
AU2002352820A8 (en) Calibration of tissue densities in computerized tomography
AU2001236798A1 (en) Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU2002353695A1 (en) Disposable apparatus for use in blood testing
EP1434876A4 (en) CREATING AN EXPRESSION PROFILE IN THE INTACT HUMAN HEART
ATE310746T1 (de) Leishmanien antigene für die verwendung in der therapie und diagnose von leishmaniose
AU2002303261A8 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
EP1451552A4 (en) FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS
AU2003292182A1 (en) Method for lowering both sequence variations and increase of base lines effects in diagnostic hybridisation assay, assay for performing such a method and probe for use in the assay
PT1454137E (pt) Utilização de um ligando marcado com especificidade para a molécula cd4 humana
DE60224259D1 (de) Reaktor sowie dessen verwendung für lösungspolymerisations- und massenpolymerisationsverfahren
AU2002305811A1 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
WO2003050499A3 (de) Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül
EG22900A (en) Diagnostic reagents and preparing methods thereof
AU5876899A (en) Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
EP1392344A4 (en) METHOD FOR MODULATING THE ACTIVITY OF CALCIUM CHANNELS IN CARDIAC CELLS AND REAGENTS FOR CARRYING OUT SAID METHOD
AU2002310415A1 (en) Carrier and specimen-handling tool for use in diagnostic testing
EP1350847A4 (en) HUMAN GLIOMANTIGEN AND METHOD FOR THE PRODUCTION THEREOF
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases